| 1 |
Chlorhexidine Gluconate, Metronidazole& Lignocaine Hydrochloride Gel |
Composition :- Chlorhexidine Gluconate Solution Equ. To Chlorhexidine Metronidazole Benzoate Equ. To Metronidazole Lignocaine Hydrochloride Gel Base |
IP IP
IP |
1%w/w 1%w/w 2%w/w q.s. |
| 2 |
Choline Salicylate & Lignocaine Hydrochloride Gel |
Composition : Choline Salicylate Solution Equ. To Choline Salicylate Lignocaine Hydrochloride Preservative:" "Benzalkonium Chloride In Pleasant Flavoured Base" |
BP IP IP |
8.7%w/w 2.0%w/w 0.01%w/w q.s |
| 3 |
Choline Salicylate, Lignocaine Hydrochloride and Benzalkonium Chloride Gel |
Composition :
Choline Salicylate Solution Equ. To Choline Salicylate Lignocaine Hydrochloride Benzalkonium Chloride
In a Flavoured Mucoadhesive gel base |
BP
IP IP |
8.7%w/w
2.0%w/w
0.01%w/w q.s |
| 4 |
Clindamycin & NicotinamideGel |
Composition: Clindamycin Phosphate Equivalent to Clindamycin Nicotinamide
Gel base |
IP IP |
1.0% w/w
4.0% w/w q.s. |
| 5 |
Clindamycin Phosphate & AdapaleneGel |
Composition Clindamycin phosphate Equivalent to clindamycin Adapalene
Gel base |
IP IP |
1 % w/w
0.1% w/w q.s. |
| 6 |
Clindamycin PhosphateGel |
Composition:- Clindamycin Phosphate Equivalent to Clindamycin
Benzoyl PeroxideAnhydrous Gel Base |
IP IP |
1.00% w/w
2.50% w/w |
| 7 |
Diclofenac , Methyl Salicylate & Menthol Topical Gel |
Diclofenac Diethylamine Eq. to Diclofenac Sodium Methyl Salicylate Menthol
Benzyl Alcohol (As Preservative) Gel Base |
IP IP IP IP IP |
2.32% w/w
2% w/w
10% w/w
5% w/w
1% w/w
q.s |
| 8 |
Diclofenac Diethyl amine, methyl Salicylate, linseed Oil &Menthol Gel |
Composition:- Diclofenac Diethyl amine
Equ. To Diclofenac Sodium 1.0%w/w)Linseed Oil Methyl Salicylate
Menthol Benzyl Alcohol Excipients |
IP
BP IP IP IP |
1.16%w/w
3.0%w/w
10.0%w/w
5.0%w/w
1.0%w/w
q.s. |
| 9 |
Diclofenac Diethylamine , Thiocolchicoside, Virgin Linseed Oil, Methyl Salicylate & Menthol Gel |
Composition : Diclofenac Diethylamine Equ. To Diclofenac SodiumThiocolchicoside Virgin Linseed Oil Menthol
Methyl Salicylate Preservative : Benzyl Alcohol Gel Base |
IP
IP BP IP IP
IP |
1.16%w/w
1.00%w/w
0.125%w/w
3.0%w/w
5.0%w/w 10%w/w
1.0%w/w q.s. |
| 10 |
Etoricoxib,Linseed Oil, Methyl Salicylate & Menthol Gel |
Etoricoxib "Linseed Oil Methyl Salicylate Menthol." |
IP BP IP IP |
1.0% W/W "3.0% W/W 10.0% W/W 5.0% W/W q.s." |
| 11 |
Fluoride Medicated Oral Gel |
Composition :
Sodium Monofluorophosphate In a Flavoured Gel base Approved Colour used |
USP |
0.35%w/w q.s |
| 12 |
Itraconazole Gel |
Composition Itraconazole Methyl Paraben Propyl Paraben In Gel base
(Itraconazole Raw material in IP 2022) |
BP IP IP |
1 % w/w
0.1% w/w
0.05% w/w q.s. |
| 13 |
Lipid Based AmphotericinB Gel 0.1%
w/w |
Each g contains: Amphotericin B Base |
IP |
1.0mg q.s. |
| 14 |
Potassium Citrate and Citric Acid Oral Solution USP |
Each 5ml contains : Potassium Citrate
Citric Acid Monohydrate Flavoured Sorbitol Base. Approved Colour Used |
IP IP |
1100mg 334mg q.s |
| 15 |
Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel |
Composition: Virgin Linseed Oil
Diclofenac Diethylamine Equ. To Diclofenac SodiumMethyl Salicyclate Menthol Capsaicin
Preservative : Benzyl Alcohol Gel Base |
BP IP
IP IP USP
IP |
3.00%w/w
1.16%w/w
1.00%w/w
10.00%w/w
5.00%w/w
0.025%w/w
1.00%w/w q.s. |
